These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21592185)

  • 1. Drug-disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activity.
    Sanaee F; Clements JD; Waugh AW; Fedorak RN; Lewanczuk R; Jamali F
    Br J Clin Pharmacol; 2011 Nov; 72(5):787-97. PubMed ID: 21592185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis.
    Mayo PR; Skeith K; Russell AS; Jamali F
    Br J Clin Pharmacol; 2000 Dec; 50(6):605-13. PubMed ID: 11136300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers.
    Ho PC; Ghose K; Saville D; Wanwimolruk S
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):693-8. PubMed ID: 11214778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil in rabbits.
    Mori Y; Hanada K; Mori T; Tsukahara Y; Hashiguchi M; Ogata H
    Biol Pharm Bull; 2001 Jul; 24(7):806-10. PubMed ID: 11456122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of controlled rheumatoid arthritis on the action and disposition of verapamil: focus on infliximab.
    Ling S; Lewanczuk RZ; Russell AS; Ihejirika B; Jamali F
    J Clin Pharmacol; 2009 Mar; 49(3):301-11. PubMed ID: 19168802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiotensin II blockade on inflammation-induced alterations of pharmacokinetics and pharmacodynamics of calcium channel blockers.
    Hanafy S; Dagenais NJ; Dryden WF; Jamali F
    Br J Pharmacol; 2008 Jan; 153(1):90-9. PubMed ID: 17965735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythromycin potentiates PR interval prolonging effect of verapamil in the rat: a pharmacodynamic drug interaction.
    Dakhel Y; Jamali F
    Toxicol Appl Pharmacol; 2006 Jul; 214(1):24-9. PubMed ID: 16466760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and gender related changes in stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil.
    Gupta SK; Atkinson L; Tu T; Longstreth JA
    Br J Clin Pharmacol; 1995 Oct; 40(4):325-31. PubMed ID: 8554934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of controlled-release verapamil in healthy volunteers and patients with hypertension or angina.
    Gupta S; Modi NB; Sathyan G; Ho Pl PL; Aarons L
    Biopharm Drug Dispos; 2002 Jan; 23(1):17-31. PubMed ID: 11891670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans: a placebo-controlled study.
    Busse D; Templin S; Mikus G; Schwab M; Hofmann U; Eichelbaum M; Kivistö KT
    Eur J Clin Pharmacol; 2006 Aug; 62(8):613-9. PubMed ID: 16823584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of grapefruit juice and smoking on verapamil concentrations in steady state.
    Fuhr U; Müller-Peltzer H; Kern R; Lopez-Rojas P; Jünemann M; Harder S; Staib AH
    Eur J Clin Pharmacol; 2002 Apr; 58(1):45-53. PubMed ID: 11956673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic effects of high-dose continuous intravenous verapamil infusion: clinical experience in the intensive care unit.
    De Cicco M; Macor F; Robieux I; Zanette G; Fantin D; Fabiani F; Nicolosi G; Fracasso A; Toffoli G; Santantonio C; Lestuzzi C; Matovic M; Boiocchi M
    Crit Care Med; 1999 Feb; 27(2):332-9. PubMed ID: 10075058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing.
    Busse D; Fromm MF; Mörike K; Drescher S; Kühlkamp V; Eichelbaum M
    Clin Pharmacol Ther; 2001 May; 69(5):324-32. PubMed ID: 11372000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metoprolol and verapamil administered separately and concurrently after single doses on liver blood flow and drug disposition.
    Bauer LA; Horn JR; Maxon MS; Easterling TR; Shen DD; Strandness DE
    J Clin Pharmacol; 2000 May; 40(5):533-43. PubMed ID: 10806607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronopharmacology of intravenous and oral modified release verapamil.
    Dilger K; Eckhardt K; Hofmann U; Kucher K; Mikus G; Eichelbaum M
    Br J Clin Pharmacol; 1999 Apr; 47(4):413-9. PubMed ID: 10233206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender-specific effects on verapamil pharmacokinetics and pharmacodynamics in humans.
    Krecic-Shepard ME; Barnas CR; Slimko J; Jones MP; Schwartz JB
    J Clin Pharmacol; 2000 Mar; 40(3):219-30. PubMed ID: 10709150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 3A5 genotype is associated with verapamil response in healthy subjects.
    Jin Y; Wang YH; Miao J; Li L; Kovacs RJ; Marunde R; Hamman MA; Philips S; Hilligoss J; Hall SD
    Clin Pharmacol Ther; 2007 Nov; 82(5):579-85. PubMed ID: 17443134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of verapamil and norverapamil enantiomers after administration of immediate and controlled-release formulations to humans:evidence suggesting input-rate determined stereoselectivity.
    Bhatti MM; Lewanczuk RZ; Pasutto FM; Foster RT
    J Clin Pharmacol; 1995 Nov; 35(11):1076-82. PubMed ID: 8626881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient kinetic and dynamic interactions between verapamil and dofetilide, a class III antiarrhythmic.
    Johnson BF; Cheng SL; Venitz J
    J Clin Pharmacol; 2001 Nov; 41(11):1248-56. PubMed ID: 11697758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of the enantiomers of verapamil after intravenous and oral administration of racemic verapamil in a rat model.
    Bhatti MM; Foster RT
    Biopharm Drug Dispos; 1997 Jul; 18(5):387-96. PubMed ID: 9210977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.